Complement lectin pathway activation is associated with COVID-19 disease severity, independent of MBL2 genotype subgroups
Description
CONCLUSION: In conclusion, activation of the MBL-LP only plays a minor role in COVID-19 pathogenesis, since no clinically meaningful, consistent associations with disease outcomes were noted.
